Snigdha Singh

Title: Snigdha Singh: Innovator in Parasitic Disease Treatment

Introduction

Snigdha Singh is a prominent inventor based in Delhi, India. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of parasitic diseases. Her innovative work has led to the development of novel compounds that hold promise for medical applications.

Latest Patents

Snigdha Singh holds a patent for "Hydroxyethylamine-based piperazine compounds, and methods of producing and using the same for treating disease." This patent discloses compounds of Formula (I) and pharmaceutically acceptable salts thereof, along with related compositions and methods for using them to treat parasitic diseases. This groundbreaking work highlights her commitment to advancing healthcare solutions.

Career Highlights

Snigdha Singh is affiliated with the National Institute of Immunology, where she conducts her research and development activities. Her role at this esteemed institution allows her to collaborate with other experts in the field and contribute to significant advancements in immunology and disease treatment.

Collaborations

Some of her notable coworkers include Brijesh Rathi and Prakasha Kempaiah. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Snigdha Singh's contributions to the field of pharmaceuticals, particularly in the treatment of parasitic diseases, underscore her role as a leading inventor. Her patent and ongoing research at the National Institute of Immunology reflect her dedication to improving health outcomes through innovative solutions.